Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Romidepsin enhances the efficacy of cytarabine <i>in vivo</i>, revealing histone deacetylase inhibition as a promising therapeutic strategy for <i>KMT2A</i>-rearranged infant acute lymphoblastic leukemia
PaperCitations, authors & open-access status
Romidepsin enhances the efficacy of cytarabine <i>in vivo</i>, revealing histone deacetylase inhibition as a promising therapeutic strategy for <i>KMT2A</i>-rearranged infant acute lymphoblastic leukemia is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 14 citations, 2019 year and gold oa status.
14
Citations
2019
Year
gold
OA Status